I think this is a terrible idea, but the motivation behind this is largely because Eli Lilly owns the patent. Lilly would like to protect the domain over that patent
For instance, Alofisel, an allogeneic adipose-derived MSC therapy for Crohns disease [179,180,181], was withdrawn from the European market in December 2024 after the latest clinical trial results showed no significant difference between it and a placebo [182]
L-NAME (5 mg/kg intraperitoneally) and/or L-arginine (100 mg/kg intraperitoneally) were given alone or together, first application at 30 min after surgery, last at 24 hours before sacrifice
It has essentially no downside at a single 4 mg dose
Each compound is supported by decades of published research from independent research groups
adjudicated death from cardiovascular causes occurred in 2.2 and 1.4 percent of patients, respectively (hazard ratio, 1.58